戻る Agenda
Perspectives on Real-World Data/Evidence Collection Through Expanded Access During the Covid-19 Pandemic
Session Chair(s)
Alison Bateman-House, PhD, MA, MPH
Assistant Professor, Division of Medical Ethics, Dept of Population Health
NYU Grossman School of Medicine, United States
A panel of international experts in drug development, patient advocacy, clinical trial design, and bioethics will discuss the role of data from expanded access and its complementary relationship to clinical trial-derived evidence.
Learning Objective : Identify policy challenges that mediate real-world data and clinical trial data collection; Assess evidence-based on real world data collected through expanded access programs; Describe successes and failures of policies based on real- world data in the Covid-19 pandemic.
Speaker(s)
Panelist
Claudia Hirawat
VOZ Advisors, United States
Executive Chair
Panelist
Tom Watson
Bionical Emas, United Kingdom
Executive Vice President, Early Access Programs
Panelist
Hayley Belli, PhD
New York University School of Medicine, United States
Assistant Professor